Image
Image
Image

模因币的四大用途:规避证券法、政治投机、慈善融资与AI启蒙

【GPT】模因币因其无用性绕过证券法,避免风险投资家获利,同时通过社交趋势、幽默和社区吸引力吸引普通投资者。它们被用于政治表达、慈善筹款、资助AI代理开发等场景,甚至成为公平启动代币的工具。尽管大多数模因币缺乏实用性,但它们通过游戏化投资过程和去中心化融资,展现了加密货币领域的创新潜力。来源于MarsBit专栏作家Max Parasol

详情

circle image

HashKey Hacker House:潜力赛道获奖项目,突破生态边界新篇

2024年12月22日晚间,由HashKey Chain主办,MetaEra、Orbiter Finance、Umy.com联合主办的「HashKey Hacker House Taichu」圆满落幕。这场以“Web3 Applications Within Regulatory Frameworks”为主题的黑客松,吸引了来自全球的优秀开发者,为探索区块链未来提供了全新的视角。

详情

最新文章

Image
Development 2024-12-24

特朗普当选后美国加密政策转鸽,还有哪些难啃的骨头呢?

在证券和银行监管领域,有可能实现更明确的规则,比如针对中心化二级市场和中心化稳定币发行人的规则。在反洗钱、税务报告和制裁方面,前景则不太明朗。

Image
Development 2024-12-26

Daos.World:MEME圈再掀起DAO基金热潮

本文将从平台架构、运作机制、参与方式等多个维度,解析这一新兴平台的特点、潜力与风险点。

Image
Development 2024-12-25

DeFi is reviving, is BTCFi Summer far away?

With the revival of DeFi, we may see BTCFi’s connection with real finance become closer. For example, the application of stablecoins in the BTCFi ecosystem will continue to expand, which will provide more efficient and low-cost solutions for cross-border payments and international trade.

Image
Development 2024-12-25

MV Global报告:DeSci有望在2025年借助MEME迎来爆发式增长

MV Global预计,Pump.Science将在2025年实现大幅扩容,预计到年底至少有10个项目的市值将超过1亿美元。

Image
Development 2024-12-25

PA Daily | UXLINK trading volume ranks first on both Upbit and Bithumb; 30 new wallets withdrew 1.37 million LINK from Binance in 5 days

MicroStrategy's stock has risen 402% this year, and Core Scientific has risen 307%; an anonymous user pledged 10,000 BTC on Babylon 10 days ago; VitaDAO plans to distribute 6.9 million BIO to VITA and VitaDAO IPT holders.

Image
Development 2024-12-26

崛起中的叙事:窥探DePIN的现在与未来

web3与真实世界交互的接口

Image
Development 2024-12-25

PA Daily | UXLINK trading volume ranks first on both Upbit and Bithumb; 30 new wallets withdrew 1.37 million LINK from Binance in 5 days

MicroStrategy's stock has risen 402% this year, and Core Scientific has risen 307%; an anonymous user pledged 10,000 BTC on Babylon 10 days ago; VitaDAO plans to distribute 6.9 million BIO to VITA and VitaDAO IPT holders.